Reason Analysis for Suspension/Early Termination of Drug Clinical Trial

Journal Title: Journal of Pharmaceutical and Biomedical Sciences - Year 2017, Vol 7, Issue 12

Abstract

Object To collect a scientific basis for improving the quality and success rate of drug clinical trials by analyzing the reasons for the suspension or termination of clinical trials in China and abroad. Method Drug Clinical Trials Registration and Information Disclosure Platform (chinadrugtrials.org.cn) and ClinicalTrials.gov (www.clinicaltrials.gov) were searched from August 1,2007 to August 1, 2017. Searches were conducted using the status “suspended” or “terminated”. Result From August 1, 2007 to August 1, 2017, the drug clinical trials of total items of which 6.30% were suspended/terminated prematurely. In the main type, by comparing the cause on Chinese and foreign clinical trials to suspend/early termination type, the results show that the two groups are similar distribution. By comparing the causes of subtypes, the most common reason for the termination of clinical trials abroad is the difficulty of recruiting subjects. The most common cause of suspension of domestic clinical trials is the decision of the sponsor. Conclusion About 59.09% of the clinical trials were due to nothing to do with the test data to suspend or early termination. While reasons are corrected, we can take the initiative to minimize the probability of clinical trials to be suspended.

Authors and Affiliations

Ying Liufu, Guohua Cheng, YiZhen Zhang, Rong Wang, Siyi Liu

Keywords

Related Articles

Influence of Ortho Group Introduction on the Alkylation of Phenolic Hydroxyl of Apocynin

Apocynin was widely studied in inflammation and oxidative stress related diseases and showed effectiveness. Structure-activity relationship study was carried out and intended to figure out new lead compounds of better ef...

Safety Evaluation of GP-EGF Lyophilised Powder

To clarify the safe risks related to the use of GP-EGF lyophilised powder (GELP), acute toxicity test, dermal allergy test, dermal irritation test, and subchronic toxicological test were evaluated according to the guidel...

Profile of Tuberculosis in AL-Diwanyah Governorate, Iraq

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. It is considered one of the most important infectious diseases in the world and its incidence is on the rise. This retrospective study aimed to...

A Promising Dual-functional Neuroprotective Derivative of Memantine

Background Memantine, an open-channel, uncompetitive blocker of NMDA receptors, is a major treatment for moderate-to-severe Alzheimer’s disease. The NMDA receptor activity can also be inhibited allosterically by S-nitros...

A Proficient Segmentation of Mesenchymal Stem Cells by Curvelet OTSU Particle Swarm Optimisation Technique

Stem cells have authored its own impact in recent times due to their promise in providing newer and unique treatments for a great range of untreatable diseases. This is due to their potential dexterity to rejuvenate and...

Download PDF file
  • EP ID EP311340
  • DOI -
  • Views 92
  • Downloads 0

How To Cite

Ying Liufu, Guohua Cheng, YiZhen Zhang, Rong Wang, Siyi Liu (2017). Reason Analysis for Suspension/Early Termination of Drug Clinical Trial. Journal of Pharmaceutical and Biomedical Sciences, 7(12), 418-423. https://europub.co.uk/articles/-A-311340